Postpartum Depression #Psychedelic Treatment Studied In Reunion's Phase 1 Trial Reunion Neuroscience has completed the data analysis for its Phase 1 clinical trial with its lead asset RE104, a 4-HO-DiPT prodrug treating #postpartum #depression. bit.ly/3GwI4XY $REUN

Prince Harry Reveals He Used Psychedelics to Cope with #Grief The Duke of Sussex' choice of phrase "clear the windshield" is symbolic of his journey with #psychedelics which allowed him to metaphorically clear away all sense of loss he was experiencing. bit.ly/3jYVggF

Congress Hops on #Psychedelics Juggernaut with a New Caucus Two #Congressmen – Lou Correa (D-CA) and Jack Bergman (R-MI) – announced they formed The Psychedelics Advancing Clinical Treatments (PACT) #caucus focused on psychedelics research & therapies. bit.ly/3GCsg6m

A brand new, fresh episode of the Psyched podcast is now live with special guest Anne Phillipi, founder of The New Health Club. Tune in to this episode to learn more about Anne’s incredible work. womeninpsychedelicsnetwork.com/annephilippi

@CybinIn announces promising results from Sponsored Kernel Flow® feasibility study measuring psychedelic effects on the brain. Find out more about the results ->buff.ly/3QPPIBs #psychedelic #medicine #research #science #clinical #doctors #HealthWorkers #MentalHeal…

A U.S. Department of Veterans Affairs official says the agency is keeping a “very close eye” on psychedelics research and policy amid the growing reform movement. buff.ly/3D9A4vk

Arizona would spend $30 million researching psychedelic mushrooms as a treatment for numerous medical conditions under a bipartisan proposal in the state capitol. buff.ly/3WqtaIZ

Let’s do a quick tour of some of the latest announcements made by psychedelics companies over the past week. We promise you’ll be informed in less time than it takes to brew your coffee. buff.ly/3iVKxUh

We are delighted to be a media partner for @PsychedelicScience 2023. Register and be a part of the largest psychedelic gathering in history. Use Women In Psychedelics discount code WPS15 for 15% off your registration. Follow @MAPS buff.ly/3PI6FNG

Apex Labs Ltd., an Iter Investment’s portfolio biopharma company developing psilocybin therapeutics, has been granted approval by Health Canada to begin its large take-home psilocybin clinical trial.  buff.ly/3XYucxn

Is this really about the depth and variety of clinical studies going after different health conditions, or is this just hype to accelerate the development of the psychedelic industry as a never-ending cure-all discovery? What are your thoughts? buff.ly/40oZEq3

It came as a surprise to many when Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat PTSD and treatment-resistant depression, respectively. buff.ly/3RLEs9Q

Will Massachusetts decriminalize the possession of psychedelic drugs? Two state legislators recently filed a bill aimed at decriminalizing certain psychedelic substances in the state. buff.ly/3YInU53

Last week, we received monumental psychedelic news out of Australia. There, regulators decided to allow psilocybin-assisted therapy to treat depression, and MDMA-assisted therapy to treat PTSD (with proper diagnosis and a prescription). Are the US and Canada next?